期刊文献+

肿瘤标志物检测在甲状腺癌临床诊治中的意义 被引量:9

Role of tumor marker in the diagnosis and treatment of thyroid carcinoma
原文传递
导出
摘要 尽管多数甲状腺癌预后较好,但依然有部分患者死于转移和复发。结合触诊、B超、核素显像及细针穿刺细胞学活检(fine needle aspiration cytology,FNAB)等对甲状腺癌进行综合评价可在一定程度上提高诊断和推断预后的精准性,但仍存在困难([5])。随着分子水平和蛋白水平对肿瘤的研究进展,与甲状腺癌发生、发展、转归和预后有关的肿瘤标志物近年颇受关注,理想的肿瘤标志物应该具有特异性高、敏感性强、可信性高的特点。现就近年常用的肿瘤标志物在甲状腺癌的诊断和评估中的临床意义作一回顾。
作者 邱杰 孙彦
出处 《山东大学耳鼻喉眼学报》 CAS 2016年第2期28-31,共4页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 肿瘤标志物 甲状腺癌 诊断 治疗 Tumor marker Thyroid carcinoma Diagnosis Treatment
  • 相关文献

参考文献19

  • 1Swiemiak M, Wojcicka A, Czetwertynska M, et al. In- depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma[ J]. J Clin Endocrinol Metab. , 2013, 98 (8) : 1401-1409.
  • 2Network CGAR: Integrated genomic characterization of papillary thyroid carcinoma [ J]. Cell, 2014, 159 ( 3 ) : 676 -690.
  • 3Qiu J, Zhang W W, Xia Q S, et al. RNA Sequencing identifies crucial genes in papillary thyroid carcinoma (PTC) progression[ J]. Exp Mol Pathol, 2016, 100( 1 ) : 151-159.
  • 4Kushchayeva Y, Jensen K, Burman J K, et al. Reposi- tioning therapy for thyroid cancer: new insights on estab- lished medications [ J]. Endocr Relat Cancer, 2014, 21 (3) :183-194.
  • 5Essig G F Jr, Porter K, Schneider D, et al. Fine needle aspiration and medullary thyroid carcinoma: the risk of in-adequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone [ J ]. Endocr Pract, 2013, 19(6):920-927.
  • 6Trimboli P, Seregni E, Treglia G, et al. Procalcitonin for detecting medullary thyroid carcinoma: a systematic re- view[J]. Endocr Relat Cancer, 2015, 22(3) :157-164.
  • 7Pazaitou-Panayiotou K, Chrisoulidou A, Mandanas S, et al. Predictive factors that influence the course of medul- lary thyroid carcinoma[J]. Int J Clin Oncol, 2014, 19 (3) :445-451.
  • 8Barbet J, Campion L, Kraeber-Bodere F, et al. Prognos- tic impact of serum calcitonin and carcinoembryonic anti- gen doubing-times in patients with medullary thyroid car- cinoma[ J]. J Clin Endocrinol Metab, 2005, 90 ( 11 ) : 6077-6084.
  • 9Bugalho M J, Santos J R, Sobrinho L. Preoperative diag- nosis of medullary thyroid carcinoma: fine needle aspira- tion cytology as compared with serum calcitonin measure- ment[ J]. J Surg Oncol, 2005, 91(1 ) :56-60.
  • 10Camacho C P, Lindsey S C, Melo M C, et al. Measure- ment of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullar- y thyroid cancer and may replace calcitonin-stimulation tests [ J ]. Thyroid, 2013, 23 (3) :308-316.

同被引文献98

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部